Zydus Lifesciences gets USFDA nod for generic medication https://ift.tt/6vLfFQY

​​Zydus has got the final approval from the US Food and Drug Administration (USFDA) to market Icosapent Ethyl Capsules in strengths of 0.5 g and 1 g, it said in a regulatory filing. The capsules are indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/D5RasBH
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.